Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report
暂无分享,去创建一个
Gabriele | L. Silverman | M. Krajinovic | D. Liang | Marie Grosjean | R. Yadav | Ramneek Gupta | A. Attarbaschi | G. Escherich | A. Möricke | S. Samarasinghe | K. Schmiegelow | M. Stanulla | I. van der Sluis | B. Wolthers | T. Frandsen | Shlomit Barzilai | A. Colombini | Ester Zápotocká | M. Tulstrup | K. K. Rasmussen | Lewis | C. Patel | I. Sluis | Rachid Abaji | Wenjian Yang | Escherich | Eric Larsen | Der-Cherng | Liang | B. Silverman | Rachita Yadav
[1] Mitchell J. Machiela,et al. LDassoc: an online tool for interactively exploring genome-wide association study results and prioritizing variants for functional investigation , 2018, Bioinform..
[2] Charles M. Perou,et al. Asparagine bioavailability governs metastasis in a model of breast cancer , 2018, Nature.
[3] R. Houlston,et al. Genome-wide association studies of cancer: current insights and future perspectives , 2017, Nature Reviews Cancer.
[4] N. Pemmaraju,et al. Questions on asparaginase-associated pancreatitis. , 2017, The Lancet. Oncology.
[5] A. Baruchel,et al. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study. , 2017, The Lancet. Oncology.
[6] A. Peters,et al. Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis , 2017, Gut.
[7] K. Schmiegelow,et al. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy , 2017, F1000Research.
[8] K. Schmiegelow,et al. Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol , 2017, Leukemia.
[9] D. Whitcomb,et al. Insights into the genetic risk factors for the development of pancreatic disease , 2017, Therapeutic advances in gastroenterology.
[10] Cheng Cheng,et al. Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] S. Bhaskar,et al. Association Analysis of PRSS1-PRSS2 and CLDN2-MORC4 Variants in Nonalcoholic Chronic Pancreatitis Using Tropical Calcific Pancreatitis as Model , 2016, Pancreas.
[12] O. Petersen,et al. Calcium and adenosine triphosphate control of cellular pathology: asparaginase-induced pancreatitis elicited via protease-activated receptor 2 , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.
[13] L. Silverman,et al. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. , 2016, The Lancet. Oncology.
[14] Daniel R. Zerbino,et al. Ensembl 2016 , 2015, Nucleic Acids Res..
[15] E. Génin,et al. Identification of a functional PRSS1 promoter variant in linkage disequilibrium with the chronic pancreatitis-protecting rs10273639 , 2015, Gut.
[16] A. Masamune,et al. Common variants at PRSS1–PRSS2 and CLDN2–MORC4 loci associate with chronic pancreatitis in Japan , 2015, Gut.
[17] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[18] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[19] Robert C. Green,et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis , 2012, Nature Genetics.
[20] K. Schmiegelow,et al. Asparaginase‐associated pancreatitis in children , 2012, British journal of haematology.
[21] Eurie L. Hong,et al. Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.
[22] A. Morris,et al. Data quality control in genetic case-control association studies , 2010, Nature Protocols.
[23] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[24] D. Neuberg,et al. Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia , 2010, Pediatric blood & cancer.
[25] D. Neuberg,et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000) , 2009, Leukemia.
[26] John P. A. Ioannidis,et al. Validating, augmenting and refining genome-wide association signals , 2009, Nature Reviews Genetics.
[27] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[28] W. Kamps,et al. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] D. Labuda,et al. Dynamic allele-specific oligonucleotide hybridization on solid support. , 2004, Analytical biochemistry.
[30] R. Gelber,et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. , 2001, Blood.
[31] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[32] D. Labuda,et al. Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay. , 1999, Analytical biochemistry.
[33] H. Müller,et al. Use of L-asparaginase in childhood ALL. , 1998, Critical reviews in oncology/hematology.
[34] D. Lancet,et al. GeneCards: integrating information about genes, proteins and diseases. , 1997, Trends in genetics : TIG.
[35] M. Gorry,et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene , 1996, Nature Genetics.
[36] 栄三 垣下,et al. L-asparaginase 療法に関する考察 , 1972 .